References

ASTRO/ASCO Consensus Guideline

Klopp A, Smith BD, Alektiar K, et al. Pract Radiat Oncol. 2014 May-Jun;4(3):137-144.

ASTRO Publication in Practical Radiation Oncology

ASCO Publication in Journal of Clinical Oncology

PORTEC Nomogram

Creutzberg CL, van Stiphout RG, Nout RA, et al. Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):530-9.

Nomograms for Prediction of Outcome With or Without Adjuvant Radiation Therapy for Patients With Endometrial Cancer: A Pooled Analysis of PORTEC-1 and PORTEC-2 Trials

Nomograms for prediction of outcome with or without adjuvant radiation therapy for patients with endometrial cancer: a pooled analysis of PORTEC-1 and PORTEC-2 trials

Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials

NCCN Guideline

NCCN Guidelines. Uterine Neoplasms. Version 3.2019

Link to NCCN Guidelines Page

Link to NCCN Uterine Neoplasms Guideline Page

PORTEC Risk Groups

Links to PORTEC1 (15 year outcomes)

Link to PORTEC1 in the IJROBP (Red Journal)

Link to PORTEC1 article in PubMed

Links to PORTEC2

Link to PORTEC2 in the Lancet

Link to PORTEC2 article in PubMed

Links to other studies using PORTEC-based risk groups

Link to Harkenrider et al (NCDB analysis with PORTEC-based risk groups)

GOG Risk Groups

Keys et al. Gynecol Oncol. 2004 Mar;92(3):744-51

PubMed link to GOG99

Adapted GOG99 Risk Group definitions

PubMed link to UCLA/RAND Analysis